Skip to content
Dose Brief
Menu
No. 407 here · Grade C

BeyondMD review

Telehealth clinic offering competitively priced compounded semaglutide and tirzepatide.

Visit BeyondMD Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $139/mo (starting dose, compounded)
Tirzepatide
From $209/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Prices read from BeyondMD's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— New to the tracker on 1 August 2026. The published line reads From $139/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

BeyondMD scored on our six Brief Score factors. See the methodology.

Price Stability48/100
Supply Reliability74/100
Transparency32/100
Access Breadth50/100
Clinical Oversight74/100
Track Record73/100

What we like

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

The caveats

  • Limited public information on program details

The brief

Best for: Readers who want mainstream telehealth GLP-1 access. Telehealth clinic offering competitively priced compounded semaglutide and tirzepatide.

Ranked #407 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about BeyondMD.

Closest here

The providers scoring nearest BeyondMD — the realistic shortlist if you're weighing it.

Weighing BeyondMD against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs BeyondMD, and every provider that outranks it is listed on the BeyondMD alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect BeyondMD's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on BeyondMD's site. Not medical advice; see our disclosure.

← Back to all rankings